HIV Prevention: PrEP/ PEP

Talks on Pre- and Post- Exposure Prophylaxis will focus on the pharmacology and the behavioral aspect of the treatments, identifying at risk populations (including guidelines for adolescents aged 13-17), and initial and follow-up screening and management.